MedTrace Logo

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

NCT00223457 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1040

Last updated 2007-01-25

No results posted yet for this study

Summary

The purpose of this study is to evaluate the coorelation between patient factors, health care provider factors, drug factors and compliance in patients with relapsing forms of multiple sclerosis (RMS) treated with Disease Modifying Agents (DMA). We hypothesize that a number of factors influence compliance with DMA's.

Conditions

Interventions

BEHAVIORAL

Factors that influence compliance

Sponsors & Collaborators

  • Biogen

    collaborator INDUSTRY

  • University of Texas Southwestern Medical Center

    lead OTHER

Principal Investigators

  • Elliot M Frohman, MD, PhD · University of Texas, Southwestern Medical Center at Dallas

  • Katherine D Treadaway, LCSW · UT Southwestern Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2005-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223457 on ClinicalTrials.gov